Investors

  • Global Health Innovation
  • LifeScan Johnson & Johnson
  • Samsung
  • Adage Capital Management
  • Alexandria Capital
  • AMV
  • DigiTx Partners
  • Excel Venture Management”
  • RS Investments

See Why We’re a Leader in Digital Therapeutics and Type 2 Diabetes Self-care

BlueStar®

Our digital health solutions are changing the face of chronic disease management, reducing costs, improving clinical outcomes, and creating hope and change for individuals living with chronic diseases.

While our current solution, BlueStar, is a robust, highly intelligent app focused on type 2 diabetes, we are also pursuing digital solutions in other therapeutic areas.

BlueStar

Clinical Evidence

Our clinical evidence shows a mean reduction of 1.7 to 2.0 point A1C drop for individuals living with type 2 diabetes who used BlueStar.

Clinical Evidence

Strategic Partners

Read What Others are Saying About Us

  • Forbes Disruptive Innovation Article
  • JAMA mHealth Coverage
  • Nature Biotechnology mHealth Coverage
  • JMIR mHealth Coverage

Digital Health Company of Firsts

WellDoc created digital health solutions long before smart phones were invented. We are the first digital health company to conduct randomized clinical trials that demonstrated significant clinical outcomes, which were published in peer-reviewed journals, and the first digital health company built on a life science business model.